{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:31:28Z","timestamp":1776713488743,"version":"3.51.2"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T00:00:00Z","timestamp":1366156800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0061939","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T20:47:03Z","timestamp":1366231623000},"page":"e61939","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation"],"prefix":"10.1371","volume":"8","author":[{"given":"Yueh-Lun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Hwa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huei-Mei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"MW Deininger","year":"2000","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2141.2001.02558.x","article-title":"Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory","volume":"113","author":"DT Holyoake","year":"2001","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/sj.leu.2402912","article-title":"Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies","volume":"17","author":"B Clarkson","year":"2003","journal-title":"Leukemia"},{"key":"ref4","first-page":"152","article-title":"Chronic myeloid leukemia in 2006: a perspective","volume":"91","author":"MJ Mauro","year":"2006","journal-title":"Heamatologica"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"H Kantarjian","year":"2002","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","article-title":"Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study","volume":"99","author":"CL Sawyers","year":"2002","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V99.6.1928","article-title":"Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study","volume":"99","author":"M Talpaz","year":"2002","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"SM Graham","year":"2002","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"X Jiang","year":"2007","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"16455","DOI":"10.1074\/jbc.271.28.16455","article-title":"The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome","volume":"271","author":"ME Figueiredo-Pereira","year":"1996","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-7258(03)00058-5","article-title":"Catalytic topoisomerase II inhibitors in cancer therapy","volume":"99","author":"AK Larsen","year":"2003","journal-title":"Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"G Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1021\/bi00478a006","article-title":"Preferential binding of daunomycin to 5\u2032ATCG and 5\u2032ATGC sequences revealed by footprinting titration experiments","volume":"29","author":"JB Chaires","year":"1990","journal-title":"Biochemistry"},{"key":"ref14","first-page":"4564","article-title":"Aclacinomycin A stabilizes topoisomerase I covalent complexes","volume":"57","author":"JL Nitiss","year":"1997","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mrgentox.2005.01.012","article-title":"Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitor","volume":"583","author":"N Hajji","year":"2005","journal-title":"Mutat Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1182\/blood.V87.7.2885.bloodjournal8772885","article-title":"Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells","volume":"87","author":"A Aries","year":"1996","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2005.09.014","article-title":"Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1","volume":"240","author":"F Morceau","year":"2006","journal-title":"Cancer Lett"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"CB Lozzio","year":"1975","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0145-2126(94)90103-1","article-title":"Leukemia cell lines: in vitro models for the study of chronic myeloid leukemia","volume":"18","author":"HG Drexler","year":"1994","journal-title":"Leuk Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0092-8674(00)00027-1","article-title":"Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis","volume":"102","author":"K Tamura","year":"2000","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbrc.2004.06.083","article-title":"Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1\/2 and deactivating p38 MAP kinase","volume":"320","author":"HM Huang","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.biocel.2007.04.016","article-title":"ERK1\/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells","volume":"39","author":"MA Moosavi","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jcp.22074","article-title":"Activin A induction of erythroid differentiation through MKK6-p38\u03b1\/p38\u03b2 pathway is inhibited by follistatin","volume":"223","author":"HM Huang","year":"2010","journal-title":"J cell Physiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jcp.21627","article-title":"c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors","volume":"218","author":"HM Huang","year":"2009","journal-title":"J cell Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/cdd.2011.155","article-title":"Regulation of CD95\/Fas signaling at the DISC","volume":"19","author":"IN Lavrik","year":"2012","journal-title":"Cell Death Differ"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jcp.21979","article-title":"Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells","volume":"222","author":"KC Chen","year":"2010","journal-title":"J Cell Physiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"T Holyoake","year":"1999","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/10428199709050893","article-title":"Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression","volume":"26","author":"P Jeannesson","year":"1997","journal-title":"Leuk Lymph"},{"key":"ref29","first-page":"835","article-title":"Pharmacokinetics of aclarubicin and its metabolites in humans and their disposition in blood cells","volume":"70","author":"S Ando","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s002800050779","article-title":"Toxicity of cytostatic drugs to normal bone marrow cells in vitro","volume":"42","author":"B Sundman-Engberg","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref31","first-page":"188","article-title":"Pharmacologic mitogen-activated protein\/extracellular signal-regulated kinase kinase\/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to Induce Apoptosis in Bcr\/Abl-expressing human leukemia cells","volume":"62","author":"C Yu","year":"2002","journal-title":"Cancer Res"},{"key":"ref32","first-page":"2118","article-title":"Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr\/Abl+ human myeloid leukemia cells","volume":"63","author":"C Yu","year":"2003","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2008.08.021","article-title":"STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis","volume":"596","author":"J Jakubowska","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.leu.2403033","article-title":"Molecular monitoring of response to imatinib (Glivec\u00ae) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission","volume":"17","author":"P Paschka","year":"2003","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11899-012-0121-6","article-title":"Chronic myeloid leukemia stem cell biology","volume":"7","author":"LA Crews","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"AS Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"10959","DOI":"10.1158\/0008-5472.CAN-06-1216","article-title":"A sequential blockade strategy for the design of combination therapies to overcome oncogene addiction in chronic myelogenous leukemia","volume":"66","author":"R Chen","year":"2006","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood-2006-10-054098","article-title":"Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells","volume":"110","author":"C Peng","year":"2007","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"32313","DOI":"10.1074\/jbc.M111.249060","article-title":"Inhibition of protein-tyrosine phosphatase 1B (PTP1B) mediates ubiquitination and degradation of Bcr-Abl protein","volume":"286","author":"D Alvira","year":"2011","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","article-title":"Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides","volume":"105","author":"KJ Aichberger","year":"2005","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1038\/sj.onc.1210587","article-title":"Sphingosine kinase-1 mediates BCR\/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells","volume":"26","author":"QF Li","year":"2007","journal-title":"Oncogene"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s00018-008-8637-6","article-title":"Mcl-1 is a potential therapeutic target in multiple types of cancer","volume":"66","author":"C Akgul","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s10495-006-9529-6","article-title":"Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL","volume":"11","author":"Z Wang","year":"2006","journal-title":"Apoptosis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.4838","article-title":"Induction of apoptosis by cancer chemotherapy","volume":"256","author":"SH Kaufmann","year":"2000","journal-title":"Exp Cell Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jcp.10256","article-title":"Overcoming resistance of cancer cells to apoptosis","volume":"196","author":"P Hersey","year":"2003","journal-title":"J Cell Physiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mito.2011.01.010","article-title":"The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis","volume":"11","author":"M H\u00fcttemann","year":"2011","journal-title":"Mitochondrion"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood.V95.7.2391","article-title":"Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways","volume":"95","author":"O Witt","year":"2000","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0186528","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0061939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T04:55:26Z","timestamp":1715230526000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0061939"}},"subtitle":[],"editor":[{"given":"Austin John","family":"Cooney","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,17]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0061939","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,17]]}}}